This webinar explains how ensuring patients are on the right medications for them — based on their DNA, as well as other important factors — can significantly reduce undesirable symptoms that are, in fact, adverse drug reactions.

In this Dark Daily webinar with live Q&A, Jeff Shaman, PhD, MS, Chief Science Officer of Coriell Life Sciences will discuss why pharmacogenomics matters and how the COVID health crisis has created unprecedented capacity and acceptance for PGx in laboratory testing.